Rote William E.'s Form 4 filing
Travere Therapeutics, Inc.TVTX · filed Jan 23, 2025
- Accession no.
- 0001415889-25-002008
- Filed
- Jan 23, 2025
- Trade date
- Jan 22, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $47.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rote William E.CIK 0001698262 | Officer (SENIOR VICE PRESIDENT, R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 22, 2025 | Common Stock | SSaleDisposed | −2,437 | $19.46 | −$47,424.02 | 83,170 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.